Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 701

1.

Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.

Biankin AV, Kench JG, Colvin EK, Segara D, Scarlett CJ, Nguyen NQ, Chang DK, Morey AL, Lee CS, Pinese M, Kuo SC, Susanto JM, Cosman PH, Lindeman GJ, Visvader JE, Nguyen TV, Merrett ND, Warusavitarne J, Musgrove EA, Henshall SM, Sutherland RL; NSW Pancreatic Cancer Network..

Gastroenterology. 2009 Aug;137(2):558-68, 568.e1-11. doi: 10.1053/j.gastro.2009.04.009.

PMID:
19376121
2.

The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer.

Riediger H, Keck T, Wellner U, zur Hausen A, Adam U, Hopt UT, Makowiec F.

J Gastrointest Surg. 2009 Jul;13(7):1337-44. doi: 10.1007/s11605-009-0919-2.

PMID:
19418101
3.

En bloc resection for locally advanced cancer of the pancreas: is it worthwhile?

Sasson AR, Hoffman JP, Ross EA, Kagan SA, Pingpank JF, Eisenberg BL.

J Gastrointest Surg. 2002 Mar-Apr;6(2):147-57; discussion 157-8.

PMID:
11992799
4.

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.

Sohn TA, Yeo CJ, Cameron JL, Koniaris L, Kaushal S, Abrams RA, Sauter PK, Coleman J, Hruban RH, Lillemoe KD.

J Gastrointest Surg. 2000 Nov-Dec;4(6):567-79.

PMID:
11307091
5.

Cyclin E expression and outcome in pancreatic ductal adenocarcinoma.

Skalicky DA, Kench JG, Segara D, Coleman MJ, Sutherland RL, Henshall SM, Musgrove EA, Biankin AV.

Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1941-7.

6.
7.

Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma.

Schmidt CM, Glant J, Winter JM, Kennard J, Dixon J, Zhao Q, Howard TJ, Madura JA, Nakeeb A, Pitt HA, Cameron JL, Yeo CJ, Lillemoe KD.

Surgery. 2007 Oct;142(4):572-8; discussion 578-80.

PMID:
17950350
8.

Preoperative platelet count predicts survival after resection of periampullary adenocarcinoma.

Schwarz RE, Keny H.

Hepatogastroenterology. 2001 Sep-Oct;48(41):1493-8.

PMID:
11677994
9.

Positive peritoneal lavage cytology is a predictor of worse survival in locally advanced pancreatic cancer.

Clark CJ, Traverso LW.

Am J Surg. 2010 May;199(5):657-62. doi: 10.1016/j.amjsurg.2010.01.021.

PMID:
20466112
10.

Number of lymph nodes evaluated: prognostic value in pancreatic adenocarcinoma.

Huebner M, Kendrick M, Reid-Lombardo KM, Que F, Therneau T, Qin R, Donohue J, Nagorney D, Farnell M, Sarr M.

J Gastrointest Surg. 2012 May;16(5):920-6. doi: 10.1007/s11605-012-1853-2.

PMID:
22421988
11.

Prediction of treatment outcome by CD44v6 after total mesorectal excision in locally advanced rectal cancer.

Peng J, Lu JJ, Zhu J, Xu Y, Lu H, Lian P, Cai G, Cai S.

Cancer J. 2008 Jan-Feb;14(1):54-61. doi: 10.1097/PPO.0b013e3181629a67.

PMID:
18303484
12.

Tumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomy.

Fortner JG, Klimstra DS, Senie RT, Maclean BJ.

Ann Surg. 1996 Feb;223(2):147-53.

13.

Prognostic factors and analysis of S100a4 protein in resected pulmonary metastases from renal cell carcinoma.

Bandiera A, Melloni G, Freschi M, Giovanardi M, Carretta A, Borri A, Ciriaco P, Zannini P.

World J Surg. 2009 Jul;33(7):1414-20. doi: 10.1007/s00268-009-0023-5.

PMID:
19365673
14.

Impact of total lymph node count and lymph node ratio on staging and survival after pancreatectomy for pancreatic adenocarcinoma: a large, population-based analysis.

Slidell MB, Chang DC, Cameron JL, Wolfgang C, Herman JM, Schulick RD, Choti MA, Pawlik TM.

Ann Surg Oncol. 2008 Jan;15(1):165-74.

PMID:
17896141
15.

The impact of lymph node number on survival in patients with lymph node-negative pancreatic cancer.

Hellan M, Sun CL, Artinyan A, Mojica-Manosa P, Bhatia S, Ellenhorn JD, Kim J.

Pancreas. 2008 Jul;37(1):19-24. doi: 10.1097/MPA.0b013e31816074c9.

PMID:
18580439
16.

S100A2 is a predictive biomarker of adjuvant therapy benefit in pancreatic adenocarcinoma.

Bachet JB, Maréchal R, Demetter P, Bonnetain F, Cros J, Svrcek M, Bardier-Dupas A, Hammel P, Sauvanet A, Louvet C, Paye F, Vaillant JC, André T, Closset J, Salmon I, Emile JF, Van Laethem JL.

Eur J Cancer. 2013 Aug;49(12):2643-53. doi: 10.1016/j.ejca.2013.04.017.

PMID:
23726265
17.

Impact of triple negative phenotype on breast cancer prognosis.

Kaplan HG, Malmgren JA.

Breast J. 2008 Sep-Oct;14(5):456-63. doi: 10.1111/j.1524-4741.2008.00622.x.

PMID:
18657139
18.

Thymidylate synthase expression in resectable and unresectable pancreatic cancer: role as predictive or prognostic marker?

Formentini A, Sander S, Denzer S, Straeter J, Henne-Bruns D, Kornmann M.

Int J Colorectal Dis. 2007 Jan;22(1):49-55.

PMID:
16538493
19.

Predictive value of the differential expression of the urokinase plasminogen activation axis in radical prostatectomy patients.

Gupta A, Lotan Y, Ashfaq R, Roehrborn CG, Raj GV, Aragaki CC, Montorsi F, Shariat SF.

Eur Urol. 2009 May;55(5):1124-33. doi: 10.1016/j.eururo.2008.06.054.

PMID:
18585843
20.

Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation.

Jhawer M, Coit D, Brennan M, Qin LX, Gonen M, Klimstra D, Tang L, Kelsen DP, Shah MA.

Am J Clin Oncol. 2009 Aug;32(4):356-62. doi: 10.1097/COC.0b013e31818c08e8.

PMID:
19381079

Supplemental Content

Support Center